We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




DNA Tests for Bioterrorism Threats

By HospiMedica staff writers
Posted on 30 Jan 2002
Field-ready DNA test kits for the rapid detection of anthrax, plague, tularemia, and botulism have been developed by Cepheid (Sunnyvale, CA, USA) in collaboration with the US Army Research Institute of Infectious Diseases (USAMRIID).

The new tests combine DNA sequences identified and validated by USAMRIID for bioterrorism-threat detection with Cepheid's proprietary reagent formulations and freeze-dry processing for prolonged stability and ease of use. More...
Cepheid has delivered the test kits to USAMRIID. They will be made available to several other US government agencies for evaluation and validation on Cepheid's Smart Cycler line of laboratory and field-portable DNA detection systems. Unlike most DNA test kits, which degrade and become ineffective after a few hours without refrigeration, Cepheid's reagent formulations and processing produce tests that remain stable for many months at room temperature. Each kit contains all the chemicals and reagents required to perform a polymerase chain reaction (PCR)-based test pre-measured and freeze-dried in a single tube. Cepheid has also developed a platform called GeneXpert that will allow minimally skilled users to obtain PCR test results from a raw sample in 30 minutes, enabling time-critical DNA tests at the point of need.

"The formulations and manufacturing process we've established will be applied to a broad spectrum of applications beyond bio-threat detection, including agricultural, veterinary, environmental, and infectious-disease testing,” said Thomas Gutshall, CEO and chairman of Cepheid.




Related Links:
Cepheid

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Ultrasound System
FUTUS LE
Imaging Table
Stille imagiQ2
Silver Member
ECG Management System
NEMS Web
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.